ImageneBio Inc (IMA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

ImageneBio Inc

NASDAQ: IMA · Real-Time Price · USD
8.51
0.66 (8.41%)
At close: Oct 01, 2025, 3:58 PM
8.80
3.41%
After-hours: Oct 01, 2025, 04:11 PM EDT

ImageneBio Inc Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 9.16M 15.62M 30.98M
Cost of Revenue
490K 1.02M 64.32M 47.11M
Gross Profit
-490K 8.14M 13.58M -16.12M
Operating Income
-58.97M -75.42M -70.9M -34.14M
Interest Income
7.37M 7.11M 2.15M 23K
Pretax Income
-49.08M -68.33M -68.77M -34.12M
Net Income
-49.23M -68.17M -68.77M -34.12M
Selling & General & Admin
23.68M 24.93M 22.2M 18.02M
Research & Development
30.39M 59.65M 64.32M 47.11M
Other Expenses
n/a -1.02M -2.03M -47.11M
Operating Expenses
54.06M 83.56M 84.49M 18.02M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
54.55M 84.58M 86.52M 65.12M
Income Tax Expense
152K -162K -2.14M 307.44K
Shares Outstanding (Basic)
48.26M 41.74M 36.19M 35.98M
Shares Outstanding (Diluted)
48.26M 41.74M 36.19M 35.98M
EPS (Basic)
-1.02 -1.63 -1.9 -0.95
EPS (Diluted)
-1.02 -1.63 -1.9 -0.95
EBITDA
-48.59M -74.4M -70.15M -33.59M
EBIT
-49.08M -75.42M -70.9M -34.14M
Depreciation & Amortization
490K 1.02M 751K 544K